Niki BioSolutions NIKI
NASDAQ NIKI
$1.93 -0.10 (-4.81%)
As of: Oct 21, 2026 · 3:59 PM EDT

Niki BioSolutions (NIKI) Short term Debt (2017 - 2022)

Updated

Niki BioSolutions' Short term Debt was $3.24 million in FY2024.

Analysis

Niki BioSolutions (NIKI) Short term Debt (2017 - 2022) Analysis & Trends

From FY2017 onward, Niki BioSolutions has reported Short term Debt for 4 years.

  • The FY2024 figure marks the highest annual Short term Debt since FY2018.
  • Per Business Quant data, Short term Debt in earlier years was $3 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Niki BioSolutions 1.04 Mn 801,227.08 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 3.00 Mn
Jun 30, 2022 3.00 Mn
Dec 31, 2018 13.50 Mn
Dec 31, 2017 480,000.00
API Access

Niki BioSolutions Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=NIKI&period=max&api_key=YOUR_API_KEY